Elon Musk’s Neuralink has seen a surge in interest for its FDA-approved human trials, with thousands of people applying to participate.
The brain-computer interface startup aims to create a direct communication and control link between humans and machines.
The process involves implanting a brain chip and ultra-thin threads through a robot, and Musk has set a target to operate on 11 people next year and over 22,000 by 2030. Musk is heavily encouraging the advance of robot surgeons to overcome the limitations of human surgeons.
Elon Musk’s company “Neuralink” is looking for a volunteer to have a piece of their skull cut open by a robotic surgeon so it can insert thin wires and electrodes into their brain. pic.twitter.com/JEP50u2ns8
— Daily Loud (@DailyLoud) November 8, 2023
However, concerns have been raised about the safety of Neuralink’s device, with both medical ethics and the SEC raising red flags.
The Director of Research Advocacy for a medical ethics committee focusing on animal rights, Ryan Merkley has spoken out against Musk’s new device.
“Patients should have serious concerns about the safety of Neuralink’s device,” cautioned Merkley.
Despite initial reservations, FDA approval was eventually granted in May 2023.
The SEC has received complaints about Musk allegedly misleading investors, but the agency has not opened an investigation on the matter.
Actor Jon Voight Slams Daughter Angelina Jolie Over Her Israel Comments
Donald Trump Reaches Major Milestone
Democrat Insults Black Voters Who Don’t Support Biden